Q32 Bio Inc. Common Stock
QTTB Real Time Price USDRecent trades of QTTB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by QTTB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Methods of treating complement mediated diseases with fusion protein constructs comprising anti-c3d antibody and a complement modulator Jan. 23, 2024
-
Patent Title: Fusion protein constructs comprising anti-c3d antibody and factor h Jul. 06, 2021
-
Patent Title: Fusion protein constructs comprising anti-c3d antibody and cr1 polypeptide Jul. 06, 2021
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of QTTB in WallStreetBets Daily Discussion
Recent insights relating to QTTB
Recent picks made for QTTB stock on CNBC
ETFs with the largest estimated holdings in QTTB
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view QTTB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.